Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities.

Clinical Trial Application filed for combined drug targeting amyloid deposits associated with Alzheimer’s Disease.

Optibrium, announced that its drug discovery platform, StarDrop, is now also available in the cloud environment.

The DeNovix CellDrop™ Automated Cell Counter has achieved ACT® Label certification from My Green Lab.

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States.

Oxford Nanopore Technologies, announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.

Global Laboratory Information Management Systems (LIMS) for the Life Sciences Industry 2023 Report benchmarked over 120 LIMS vendors and placed LabVantage in No. 1 spot for growth.

The Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.